Professional Documents
Culture Documents
RIDL
RIDL
RIDL
Sex-separation
Released sterile females- detrimental to control programme
Difficulties in discrimination
Fig.2: Estimated number of wild flies population(FTD) in areas of petapa and VIENNA4/Tol-94 strains
released
Fig.3: Comparison of induced egg sterility between Petapa and VIENNA 4/Tol-94 strains
Types
Bisex RIDL
Female-specific RIDL
SIT and RIDL
no. of generations
Asokan, 2007
In 2000, Thomas et al., developed RIDL system in Drosophila
melanogaster using Drosophila transcriptional control elements
Table3: Viability of males and females carrying one copy each of the tetO-hid
and yp1-tTA constructs
Fu et al., 2010
OX3604C with tRe- DsRed2
• tTAV under the control of a promoter fragment from AeAct4.
• translation initiation codon (ATG) 5’
• VP16 under control of tRe
• fluorescent marker (DsRed2) under control of the Hr5-IE1 promoter
Fu et al., 2010
A
Fu et al., 2010
Table 6: Flight ability of females
Pipeline of products designed to address insect pests of Public Health and Agriculture
OX513A
OX513A is a female specific Aedes aegypti RIDL strain
Late acting lethality
DsRed marker
Current Status
It has regulatory approvals for import and contained testing in
Brazil, Cayman Islands, France, India, Malaysia, USA and
Vietnam
Late lethality
Current Status
Available in a Mexican genetic background
Consortium member has obtained a permit for import into
Mexico and will evaluate the strain in large scale outdoor
cages in Chiapas in December, 2011.
Fu et al., 2010
OX1138
Genetically Engineered Pink bollworm (Pectinophora
gossypiella)
OX1138 contains a fluorescent marker
Current Status
The strain has been evaluated in three years of open release
trials by the USDA-APHIS Plant Protection and Quarantine
and CPHST.
Current Status
It has been tested at Oxitec for conditional lethality, marker
performance and mating competitiveness
Fu et al. 2010
OX3402
Pink bollworm bisex RIDL strain with fluorescent marker
Current Status
CPHST- to be test under field conditions in Dec, 2011 in
south-western USA.
Current Status
OX3713A has now been optimized by Oxitec. It is now
available for evaluation for open field trials